Researchers at University of the Pacific in Stockton have developed a long-acting opioid overdose-reversal drug-delivery system that could save lives.

New Monash University research has revealed a concerning rise in new opioid prescriptions among younger Victorians, while ...

More New Yorkers received scripts for buprenorphine, a med used to treat opioid addiction, amid fight against record-high ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

After years of struggling with alcohol dependence, Shana found a combination of treatment and counseling that works for her.

Donald Trump has imposed tariffs on Mexico, Canada, and China, citing the fentanyl crisis as a significant issue exacerbating ...

ALBANY — An investigation into a series of episodes in which state prison workers have been rushed to hospitals after ...

The story of Hamilton County is the story of much of America in 2025. Overdose deaths have fallen sharply, offering hope the ...

Naloxone displaces the opioid from the brain receptors, which stops the effects of the overdose for sixty to ninety minutes. This allows time for a hospital to intervene.

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non ...

A University of the Pacific team has developed a single-dose injection to counter the effects of fentanyl and other opioid ...